Banka BioLoo Limited

Banka BioLoo FY26 Earnings Recovered; FY27 Focus on Cash Conversion & Profitability

Banka BioLoo reported FY26 total income of ₹58.4 crore (+7.1%) and EBITDA of ₹6.49 crore. The company aims to convert contracted revenues into cash and sustainable profitability in FY27. The order book stands at ₹107 crore. Megaliter's portfolio LTV is ₹122 crore.

Banka BioLoo Holds 14th AGM on Sep 17, 2026

Banka BioLoo Limited held its 14th AGM on September 17, 2026. Key agendas included adopting FY26 financial statements and approving related party transactions. Remote e-voting concluded on September 16, 2026. Voting results will be announced within two working days.

Banka BioLoo to hold 14th AGM on Sept 17

Banka BioLoo Limited will hold its 14th Annual General Meeting on September 17, 2026, at 3:00 PM via video conferencing. The AGM notice and Annual Report have been dispatched.

Banka BioLoo to hold 14th AGM on Sep 17, 2026, to approve FY26 financials & RPTs

Banka BioLoo Limited will hold its 14th AGM on September 17, 2026, via video conference. Key agenda items include adopting the FY26 audited financial statements and approving material related party transactions with its subsidiary, Megaliter Varunaa Private Limited. Mrs. Namita Sanjay Banka is set for re-appointment as director.

Banka BioLoo Announces AGM on Sep 17, 2026; Book Closure Sep 11-17

Banka BioLoo Limited will hold its 14th Annual General Meeting on September 17, 2026. The company's books will be closed from September 11 to September 17, 2026. The cut-off date for voting eligibility is September 10, 2026. Remote e-voting will be open from September 13 to September 16, 2026.

Banka BioLoo: AGM on Sep 17, Book Closure Sep 11-17

Banka BioLoo Limited will hold its 14th Annual General Meeting on September 17, 2026. The company's books will be closed from September 11 to September 17 for this purpose. The cut-off date for voting eligibility is September 10, 2026. Remote e-voting is open from September 13 to September 16.

Banka BioLoo Announces 14th AGM on Sep 17, 2026, to Discuss FY26 Results & RPTs

Banka BioLoo Limited will hold its 14th AGM on September 17, 2026, via VC/OVAM. Key agenda items include adopting FY26 financial results and approving material related party transactions with subsidiary Megaliter Varunaa Private Limited. Mrs. Namita Sanjay Banka is set for re-appointment as director. The cut-off date for voting eligibility is September 10, 2026.

Banka BioLoo Announces 14th AGM on Sep 17, 2026

Banka BioLoo Limited will hold its 14th Annual General Meeting on September 17, 2026. The meeting will be conducted via video conferencing, as per regulatory requirements.

Banka BioLoo Announces Publication of Financial Results for Q1 FY27

Banka BioLoo Limited published its un-audited financial results for the quarter ended 30 June 2026 on 15 August 2026. The results were advertised in the Financial Express and Nava Telangana newspapers, in compliance with SEBI regulations. The information is also available on the company's website.

Banka BioLoo: Certificate of Compliance Not Applicable for Q1 FY27

Banka BioLoo Limited confirms that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, is not applicable for the quarter ended June 30, 2026. This confirmation was received from their RTA, Bigshare Services Private Limited, via a letter dated July 4, 2026.

Banka BioLoo Closes Trading Window July 1 to Post Q1 FY27 Results

Banka BioLoo Limited will close its trading window from July 1, 2026. The window will reopen 48 hours after the announcement of the un-audited financial results for the quarter ending June 30, 2026. Directors and designated persons are restricted from trading securities during this period.

Banka BioLoo Repays ₹4.3 Crore in NCDs, Receives No Due Certificate

Banka BioLoo Limited has fully repaid ₹4.30 crore in secured, unlisted Non-Convertible Debentures (NCDs). The company received a No Due Certificate on June 25, 2026, confirming the repayment was completed on June 22, 2026.

Banka BioLoo Publishes Audited Financial Results in Newspapers

Banka BioLoo Limited published its audited financial results for the quarter and year ended March 31, 2026, on May 28, 2026. The results were advertised in "Financial Express" and "Nava Telangana" newspapers, complying with SEBI regulations.

Banka BioLoo Approves FY26 Audited Results, Appoints New Company Secretary

Banka BioLoo's Board approved audited standalone and consolidated financial results for the year ended March 31, 2026. Ms. Srilakshmi Manjula Chaitanya Chunduru was appointed Company Secretary and Compliance Officer. SMAB & Associates appointed as Internal Auditors for FY 2026-2027.

Banka BioLoo Q4FY26 Results: Revenue Up 29% YoY to ₹18.02 Cr, PAT Turns Positive

Banka BioLoo Limited reported a strong Q4 FY26 with revenue up 29% YoY to ₹18.02 Cr and PAT turning positive at ₹157.1 Lakhs. Full-year PAT also turned positive at ₹38.2 Lakhs. The company's 12-month order book stands at ₹107 Crore, with significant contributions from both Railways and WaSH segments.

Banka BioLoo Appoints Srilakshmi Chunduru as Company Secretary & Compliance Officer

Banka BioLoo Limited has appointed Ms. Srilakshmi Manjula Chaitanya Chunduru as the new Company Secretary and Compliance Officer, effective May 26, 2026. She is authorized, along with the CEO and CFO, to determine the materiality of events and make disclosures to stock exchanges as per SEBI regulations.

Banka BioLoo Appoints Company Secretary and Internal Auditors

Banka BioLoo Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Ms. Srilakshmi Manjula Chaitanya Chunduru was appointed Company Secretary and Compliance Officer from May 26, 2026. M/s. SMAB & Associates were appointed as Internal Auditors for FY 2026-27.

Banka BioLoo Approves FY26 Financial Results; Appoints New Company Secretary

Banka BioLoo Limited approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company appointed Ms. Srilakshmi Manjula Chaitanya Chunduru as Company Secretary and Compliance Officer. M/s. SMAB & Associates were appointed as Internal Auditors for FY27.

Banka BioLoo Appoints New Company Secretary & Compliance Officer; Approves Financial Results

Banka BioLoo approved audited financial results for FY26 ended March 31, 2026. Ms. Srilakshmi Manjula Chaitanya Chunduru was appointed Company Secretary and Compliance Officer from May 26, 2026. SMAB & Associates appointed as Internal Auditors for FY27. Amended policies were also adopted.

Banka BioLoo Approves FY26 Financial Results, Appoints New Company Secretary

Banka BioLoo Limited's Board approved audited standalone and consolidated financial results for the year ended March 31, 2026. Ms. Srilakshmi Manjula Chaitanya Chunduru was appointed Company Secretary and Compliance Officer. SMAB & Associates appointed as Internal Auditors for FY 2026-27.

Banka BioLoo Approves FY26 Audited Results; Appoints New Company Secretary

Banka BioLoo Limited's Board approved audited standalone and consolidated financial results for FY26 ended March 31, 2026. Ms. Srilakshmi Manjula Chaitanya Chunduru was appointed Company Secretary and Compliance Officer from May 26, 2026. SMAB & Associates appointed as Internal Auditors for FY27.

Banka BioLoo Files SEBI Takeover Regulations Declaration for FY26

Banka BioLoo Limited filed a declaration under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2026. The declaration was received from a promoter and submitted to the National Stock Exchange.

Banka BioLoo Limited: Company Secretary & Compliance Officer Resigns

Mrs. Nitika Lakhotia has resigned as Company Secretary and Compliance Officer of Banka BioLoo Limited. Her resignation is effective April 30, 2026. She is leaving to pursue external career opportunities. The company has accepted her resignation.

Banka BioLoo Clarifies Price Surge: Attributes to Market Conditions

Banka BioLoo Limited clarifies that its recent stock price surge is market-driven and not due to any undisclosed company-specific information. The company assures adherence to SEBI disclosure norms.

Banka BioLoo: Compliance Certificate Not Applicable for Q4FY26

Banka BioLoo Limited confirms that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, is not applicable for the quarter ended March 31, 2026. This confirmation was received from their RTA, Bigshare Services Private Limited.

Banka BioLoo Provides Rs. 10 Crore Corporate Guarantee to Subsidiary

Banka BioLoo Limited will provide a Corporate Guarantee of up to ₹10 Crores to its subsidiary, Megaliter Varunaa Private Limited, for a credit facility. The guarantee is unconditional and irrevocable.

Banka BioLoo: Trading Window Closed for Q4FY26 Results

Banka BioLoo's trading window will be closed from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and fiscal year ending March 31, 2026. This is in compliance with SEBI regulations. The date for the board meeting to approve the results will be announced later.

Banka BioLoo Provides ₹4.35 Crore Corporate Guarantee for Subsidiary

Banka BioLoo Limited will provide a Corporate Guarantee of up to ₹4.35 Crores for its subsidiary, Megaliter Varunaa Private Limited. The guarantee secures a credit facility from Maanaveeya Development & Finance Private Limited. The decision was made by the Operations Committee on February 27, 2026.

Banka BioLoo Publishes Q3FY26 Unaudited Financial Results in Newspapers

Banka BioLoo Limited published its unaudited financial results for Q3FY26 and the nine months ended December 31, 2025, on February 13, 2026. Future results for FY27 are scheduled for May 12, June 12, July 12, and August 12. The company also highlighted its Swachh Bharat Abhiyan initiative, aiming to provide sanitation to 500 villages.

Banka BioLoo Q3FY26 Investor Presentation: Revenue Up 12%, EBITDA Turns Positive

Banka BioLoo reported Q3 FY26 consolidated revenue of ₹1,526.49 Lakhs (up 8% YoY) and standalone revenue of ₹1,592.86 Lakhs (up 15% YoY). Standalone EBITDA turned positive at ₹90 Lakhs, a significant improvement. The company has an unexecuted order book of ₹113 Crores, including ₹49.5 Crores in Railways and ₹63.5 Crores in WaSH.

Banka BioLoo Declares Q3 FY26 Unaudited Financial Results

Banka BioLoo Limited approved its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board Meeting was held on February 12, 2026.

Banka BioLoo Q3 FY26 Results: Net Loss Widens to ₹12.45 Lakhs

Banka BioLoo Limited reported its unaudited financial results for the quarter ended December 31, 2025. The company incurred a net loss of ₹22.01 Lakhs on a standalone basis and ₹12.45 Lakhs on a consolidated basis. Total income for the quarter was ₹1597.28 Lakhs (standalone) and ₹1531.54 Lakhs (consolidated).

Banka BioLoo: NSE Approves Listing of 29,575 ESOP Equity Shares Effective Jan 23

Banka BioLoo Limited received NSE approval for listing and trading of 29,575 equity shares allotted under ESOP. The shares have a face value of ₹10 each. Trading is effective from 23 January 2026.

Banka BioLoo: Certificate of Compliance Not Applicable for Q3 FY26

Banka BioLoo Limited confirms that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, is not applicable for the quarter ended December 31, 2025. Confirmation received from RTA, Bigshare Services Private Limited.

Banka BioLoo: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results

Banka BioLoo Limited will close its trading window from January 1, 2026, until 48 hours post-declaration of Q3 FY26 financial results. Directors and designated persons are prohibited from trading securities during this period. The board meeting date for results approval will be announced later.

Banka BioLoo Limited: Newspaper Publication of Financial Results

Banka BioLoo Limited publicized unaudited financial results (standalone & consolidated) for the quarter and half-year ended 30 September 2025 in newspapers on 16 November 2025, complying with SEBI regulations.

Banka BioLoo Reports Improved Q2 FY26 Results, Strong Order Book, and Strategic Achievements

Banka BioLoo announced Q2 FY26 results with reduced losses and increased revenue. The company secured ₹22 crore in new orders and achieved significant milestones in sustainability programs and subsidiary funding.

Banka BioLoo Approves Unaudited Financial Results for Quarter Ended Sep 2025

Banka BioLoo's board approves unaudited financial results for the quarter ended September 30, 2025, for both standalone and consolidated financials, following Audit Committee recommendations.

Banka BioLoo Board Approves Q2 and Half-Year Ended September 2025 Financial Results

Banka BioLoo approved Q2 and H1 FY26 standalone and consolidated financial results, reporting net losses for both periods. Revenue declined, impacting profitability significantly.

Trading Approval Granted for ESOP Allotment of 8,750 Equity Shares

NSE grants listing and trading approval for 8,750 equity shares of ₹10 each, allotted under ESOP. Approval date: 23 October 2025. Effective date: 24 October 2025.

Non-applicability of Regulation 74(5) for Quarter Ended 30 September 2025

Banka BioLoo Limited confirms non-applicability of SEBI regulation 74(5) for the quarter ended 30 September 2025, based on confirmation from their RTA, Bigshare Services Private Limited.

Banka BioLoo enters into Restated and Amended Shareholders’ Agreement

Banka BioLoo Reconstitutes Audit and Nomination & Remuneration Committees

Banka BioLoo's Subsidiary Megaliter to Raise Capital from External Investors; Parent to Retain Control

Banka BioLoo's subsidiary, Megaliter, to raise capital; shareholding to dilute to 70%

Banka BioLoo announces Non-Executive Independent Director Aparajita Agrawal's retirement

Banka BioLoo: AGM Approves Director Re-appointments & Appointment

Banka BioLoo Shareholders Approve Secretarial Auditor Appointment

13th AGM of Banka BioLoo Limited to be held on 10 September 2025

Banka BioLoo announces publication of Financial Results in Newspapers